$IMCR News

Will Kimmtrak Continue to Aid IMCR's Growth Through the Rest of 2026?

JP Morgan Reinstates Overweight on Immunocore Holdings, Announces $50 Price Target

Wall Street Analysts See a 77.91% Upside in Immunocore (IMCR): Can the Stock Really Move This High?

How Strong H1 Profits and Kimtrak Survival Data At Immunocore (IMCR) Have Changed Its Investment Story

Immunocore Holdings plc 2026 Q2 - Results - Earnings Call Presentation

Immunocore Q2 Earnings Call Highlights

Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Kimtrak Growth and Pipeline ...

Immunocore Holdings plc (IMCR) Q2 2026 Earnings Call Transcript

Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Strong Kimtrak Growth and ...

Immunocore (NASDAQ:IMCR) Q2 Revenue Beats but EPS Misses, Shares Tumble

Immunocore reports second quarter financial results and provides a business update

Immunocore Hldgs Q2 EPS $(0.02) Misses $0.02 Estimate, Sales $115.927M Beat $110.374M Estimate

Mizuho Maintains Neutral on Immunocore Holdings, Raises Price Target to $35

Immunocore to report second quarter 2026 financial results and host call on August 6, 2026

Is Immunocore Holdings (IMCR) Undervalued After Its Recent Share Price Rebound?

Immunocore: KIMMTRAK Is Becoming A Cash Engine For A Much Larger TCR Platform

Wall Street Analysts Think Immunocore (IMCR) Could Surge 111.53%: Read This Before Placing a Bet

A Look At Immunocore (IMCR) Valuation After Strong Q1 2026 Results And New KIMMTRAK Survival Data

Immunocore (IMCR) Is Up 10.1% After Q1 Profitability Jumps On Higher Revenue And Efficiency

Immunocore reports first quarter financial results and provides a business update